By Mill Chart
Last update: Mar 1, 2024
Unearth the potential of WEST PHARMACEUTICAL SERVICES (NYSE:WST) as a dividend stock recommended by our stock screening tool. NYSE:WST maintains a robust financial footing and delivers a sustainable dividend. We'll delve into the details below.
ChartMill assigns a proprietary Dividend Rating to each stock. The score is computed by evaluating various valuation aspects, like the yield, the history, the dividend growth and sustainability. NYSE:WST was assigned a score of 7 for dividend:
ChartMill utilizes a Health Rating to assess stocks, scoring them on a scale of 0 to 10. This rating takes into account a variety of liquidity and solvency ratios, both in absolute terms and in comparison to industry peers. NYSE:WST has earned a 8 out of 10:
ChartMill assigns a proprietary Profitability Rating to each stock. The score is computed by evaluating various profitability ratios and margins and ranges from 0 to 10. NYSE:WST was assigned a score of 9 for profitability:
More Best Dividend stocks can be found in our Best Dividend screener.
For an up to date full fundamental analysis you can check the fundamental report of WST
Important Note: The content of this article is not intended as trading advice. It is essential to perform your own analysis and exercise caution when making trading decisions. The article presents observations created by automated analysis but does not guarantee any trading or investment outcomes. Always trade responsibly and make independent judgments.
WEST PHARMACEUTICAL SERVICES
NYSE:WST (4/18/2024, 7:04:00 PM)
After market: 377.33 0 (0%)377.33
-0.03 (-0.01%)
Is WEST PHARMACEUTICAL SERVICES (NYSE:WST) a Good Fit for Dividend Investing?
/PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced...
Discover top pharma stocks to sell in March before they plummet. Learn why ACAD, AMLX and WST are on the list for urgent sell-off decisions.
/PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced...
West Pharmaceutical (WST) declares $0.20/share quarterly dividend, in line with previous. Forward yield 0.22% Payable May 1; for shareholders of record April 24
/PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced today...
West Pharmaceutical Services reports Q4 2023 adjusted EPS at $1.83, surpassing consensus. Quarterly sales hit $732 million missing estimates. 2024 guidance hints at moderated organic growth, emphasizing inventory management strategies.